Debate on DTC Advertising Heats Up!
Introduction to this Special Issue: This past June, the American Medical Association (AMA) joined myriad other consumer and medical interest groups to ask the question whether direct-to-consumer (DTC) advertising by pharmaceutical companies had gotten out of hand. Sensing the way the winds were blowing, the pharmaceutical industry's trade group PhRMA (Pharmaceutical and Research Manufacturers of America) announced on Aug. 2 that it would self-police DTC drug advertising practices by signing up pharmaceutical manufacturers to a voluntary agreement to follow PhRMA's new DTC policies. In this issue, we will look at those policies and at the reactions they caused in the medical, legislative and consumer communities.
New PhRMA Policy: Not Everyone Satisfied
When the Pharmaceutical and Research Manufacturers of America (PhRMA) announced it was instituting a new policy on direct-to-consumer advertising, PhRMA President and CEO Billy Tauzin stated, "With these principles, we commit ourselves to improving the inherent educational value of advertisements. Patients need accurate and timely information and should be encouraged to discuss diseases and treatment options with their physicians. These principles will help us reach that goal."
Features
PhRMA's New Rules on DTC Advertising
In response to continued scrutiny from the public and from legislators concerned over the effects of direct-to-consumer (DTC) advertising, the Board of Directors of the Pharmaceutical Research and Manufacturers Association (PhRMA) voted this past July 29 to institute what it calls a set of "Guiding Principles" that will extend and augment the current FDA rules for DTC advertisement. These principles will go into effect in January 2006.
Perez v. Wyeth and Direct-to-Consumer Ads
Six years ago, in <i>Perez v. Wyeth Laboratories Inc.</i>, 161 N.J. 1 (1999), the New Jersey Supreme Court enunciated a novel exception to the learned intermediary doctrine intended to address the rise of direct-to-consumer (DTC) marketing of prescription pharmaceuticals. The learned intermediary doctrine is a common law principle, codified in many states, that shields prescription pharmaceutical manufacturers from liability for failing to warn consumers of the potential side-effects associated with their products as long as they have adequately warned prescribing physicians. The <i>Perez</i> court, however, held that when pharmaceutical companies employ DTC advertising, there is an additional duty to warn consumers of potential risks.
Domestic Violence: Family Law Attorneys Can Get Caught in the Crossfire
Domestic violence probably impacts at least a few, if not several, of the clients you assist each year. In this Special Issue, we focus on some of the problems endemic to domestic violence: the plight of the victim when police protection is inadequate; the consequences to the perpetrator when Family Court issues impact on Criminal Court proceedings, and vice versa; and what can happen to attorneys who get swept up in their clients' problems to become potential victims of violence themselves.
Family and Criminal Courts: Overlapping Considerations
When accusations of domestic violence or child sexual abuse are brought in a family matter, the attorney for the accused party has a lot to think about. How to prove that no abuse occurred, that the client has reformed or that it was a one-time occurrence that won't happen again? Such issues can command a lot of the attorney's focus. But because matters surrounding spousal or child abuse accusations often are or will later become germane to a criminal case, family law attorneys have extra considerations apart from the outcome of the divorce or custody matter. How might criminal proceedings impact custody issues? Will the facts that come out in Family Court affect a later criminal prosecution? When admissions of criminal behavior are elicited in Family Court, do constitutional protections afforded to criminal defendants attach?
New York: Law Enforcement Liability in Domestic Cases
On June 27, the U.S. Supreme Court rendered its decision in <i>Town of Castle Rock v. Gonzales</i>, 2005 U.S. LEXIS 5214, the civil rights case that asked whether a court-issued domestic restraining order, whose enforcement is mandated by a state statute, creates a property interest protected by the due process clause of the Fourteenth Amendment. The Supreme Court's decision reversed the Tenth Circuit Court of Appeals' finding that the restraining order, coupled with the Colorado statute mandating the enforcement of such orders (<i>see</i> Colo. Rev. Stat. ' 18-6-803.5(3)), established a protected property interest in the enforcement of the restraining order which could not be taken away by the government without procedural due process.
Features
Case Briefs
Highlights of the latest insurance cases from around the country.
The Hazards of an Untimely Disclaimer of Coverage: Application of the Estoppel Doctrine to Bar Reliance upon Coverage Defenses
Liability insurance policies typically require the insured to notify the insurance company "as soon as practicable" or "as soon as possible" of a suit or a potentially covered claim. Compliance with these "notice conditions" is often held to be a condition precedent to coverage under the policy, such that if the insured unreasonably delays notifying its carrier of a suit or claim, the insurer may be relieved of its duties under the policy. The purpose of these provisions is to protect the insurer by giving it adequate time to investigate the claim, control the litigation, posture the case for settlement, set reserves, and prevent fraud. <i>Sybron Transition Corp. v. Sec. Ins. Co. of Hartford</i>, 107 F.3d 1250, 1257 (7th Cir. 1997). But there is a cautionary note for insurers because the duty to provide prompt notice is not limited to the insured. Under limited circumstances, an insurer may be estopped from relying upon a coverage defense, such as late notice or an applicable exclusion from coverage, if it unreasonably delays denying coverage under the policy because, just like the insurer, the insured can potentially suffer prejudice from untimely communications. <i>Incorporated Village of Pleasantville v. Calvert Ins. Co.</i>, 612 N.Y.S.2d 441 (N.Y. App. Div. 1994); <i>Central Mut. Ins. Co. v. Kammerling</i>, 571 N.E.2d 806 (Ill. App. Ct. 1991). This article discusses the elements of estoppel barring coverage defenses, application of the defense in special circumstances involving settlement of the underlying claim, and what an insurer should do if it is uncertain as to whether coverage actually exists under the policy.
Mess in Texas: Insurer Recoupment of Settlement Payments
The Texas Supreme Court unanimously has held that an insurer may recover from its own insured monies advanced by the insurer to settle an uncovered liability claim ' though the justices sharply divided on the rationale. The case, <i>Excess Underwriters at Lloyd's, London v. Frank's Casing Crew & Rental Tools, Inc.</i>, No. 02-0730 (Tex. May 27, 2005), picks up the cudgels on this issue from the California Supreme Court's opinion in <i>Blue Ridge Ins. Co. v. Jacobsen</i>, 22 P.3d 313 (Cal. 2001) and seemingly abandons the prior decision in <i>Texas Ass'n of Counties County Gov't Risk Mgmt. Pool v. Matagorda County</i>, 52 S.W.3d 128 (Tex. 2000), which had cast substantial doubt on the viability of an insurer-recoupment claim, at the time seeming to bring Texas in line with Massachusetts on this issue. <i>See Med. Malpractice Joint Underwriting Ass'n of Massa-chusetts v. Goldberg</i>, 680 N.E.2d 1121 (Mass. 1997). <i>Frank's Casing</i> also parts company with the recent holding of the Illinois Supreme Court in <i>General Agents Insurance Company Of America, Inc. v. Midwest Sporting Goods Company</i>, 828 N.E.2d 1092 (Ill. March 24, 2005), which had rejected a carrier's claim for recoupment of defense costs, though on a basis that would bar recoupment of settlement or indemnity payments, too.
Need Help?
- Prefer an IP authenticated environment? Request a transition or call 800-756-8993.
- Need other assistance? email Customer Service or call 1-877-256-2472.
MOST POPULAR STORIES
- Strategy vs. Tactics: Two Sides of a Difficult CoinWith each successive large-scale cyber attack, it is slowly becoming clear that ransomware attacks are targeting the critical infrastructure of the most powerful country on the planet. Understanding the strategy, and tactics of our opponents, as well as the strategy and the tactics we implement as a response are vital to victory.Read More ›
- The DOJ's New Parameters for Evaluating Corporate Compliance ProgramsThe parameters set forth in the DOJ's memorandum have implications not only for the government's evaluation of compliance programs in the context of criminal charging decisions, but also for how defense counsel structure their conference-room advocacy seeking declinations or lesser sanctions in both criminal and civil investigations.Read More ›
- Use of Deferred Prosecution Agreements In White Collar InvestigationsThis article discusses the practical and policy reasons for the use of DPAs and NPAs in white-collar criminal investigations, and considers the NDAA's new reporting provision and its relationship with other efforts to enhance transparency in DOJ decision-making.Read More ›
- The DOJ's Corporate Enforcement Policy: One Year LaterThe DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.Read More ›
- Disney-OpenAI’s Sora Deal: What it Signals for Licensing and Responsible AIThe Walt Disney Co.’s newly announced, three-year licensing agreement with OpenAI to bring more than 200 characters from Disney, Marvel, Pixar and Star Wars to Sora marks a pivotal moment at the intersection of intellectual property and generative AI. For rights holders, platforms, and brands, the deal illustrates an emerging blueprint for commercializing iconic IP in AI-native formats while attempting to manage legal, regulatory, and reputational risk.Read More ›
